Explorer
Advertisement
Covovax
India
Serum Institute Seeks Drug Regulator's Approval Of Covovax As Covid Booster Dose: Report
Health
SII Working With US Firm To Launch Omicron-Specific Covid Vaccine After Six Months: Adar Poonawalla
Health
DCGI Approves Serum Institute's Covovax Covid Vaccine For 7-11 Age Group: Report
Health
DCGI Recommends Emergency Use Authorisation To SII's Covovax For Children Aged 7-11 Years
Health
EXPLAINED: As India Clears SII's Covovax, Know What Is A Nanoparticle-Based Vaccine And How It Works
India
SII's Covid Vaccine Covovax Available For Everyone Above 12 Yrs, Says Adar Poonawalla
News
SII's Covovax Covid Vaccine Now Available For Children In India, Says CEO Adar Poonawalla
Health
NTAGI Approves SII's Covovax Covid-19 Vaccine For Children Between 12-17 Age Group: Report
India
Covovax First Indian COVID Vaccine To Be Sold In Europe, Says SII's Adar Poonawalla
India
Govt Panel Recommends SII-Manufactured Covovax In Vaccination Drive For 12 Yrs And Above
India
Novovax Covid-19 Vaccine Gets Emergency Use Approval For Kids Aged 12-18 Years In India
India
SII's Covovax Gets Emergency Approval For Children Aged 12-17 Years
Short Videos
Advertisement
Advertisement
Advertisement
Top Headlines
India
Cities
India
Cities
Advertisement